Recommended and Prevalent Use of Glucagon-like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors in a National Population-Based Sample.
Shichao TangStephen R BenoitMohammed K AliPing ZhangPublished in: Annals of internal medicine (2023)
Keyphrases